Free PMHNP board review · 10 practice questions
PMHNP Neurotransmitter Practice Questions
Connect neurotransmitters, dopamine pathways, and medication effects.
Independent educational practice, not official ANCC exam items. Not affiliated with or endorsed by ANCC. Not individual clinical advice; use current prescribing information, local protocols, and clinical judgment in practice.
Choose an answer, then review the why
Pick your best answer, then open Show answer and explanation to review the reasoning for every option.
Self-paced · No login · Answers aren’t saved or scored. Open and close explanations as often as you like.
Question 1 of 10
A patient with schizophrenia reports that voices are less frequent and the belief that neighbors are monitoring them has become less convincing after starting a D2-blocking antipsychotic. In the classic dopamine-pathway teaching model, which pathway is most closely linked to improvement in these positive symptoms?
Show answer and explanation for question 1
Correct answer: B. Mesolimbic pathway
The key clues are hallucinations and delusions: positive psychotic symptoms. The classic teaching model connects these symptoms with mesolimbic dopamine signaling. Use that association as a learning framework; psychosis involves broader brain circuits and cannot be explained by excess dopamine in one pathway alone.
Why the other answers are less appropriate
- A. Nigrostriatal pathway: Nigrostriatal signaling is most useful here for understanding movement and antipsychotic-related parkinsonism.
- C. Tuberoinfundibular pathway: Tuberoinfundibular dopamine regulates prolactin secretion; blockade can cause hyperprolactinemia.
- D. Mesocortical pathway: Mesocortical projections reach the prefrontal cortex and are associated with cognition and the classic model of negative symptoms.
Question 2 of 10
A patient with schizophrenia has persistent difficulty organizing tasks and holding information in working memory, even though hallucinations have improved. The PMHNP explains that dopamine signaling to the prefrontal cortex is one part of the circuitry involved. Which pathway is being described?
Show answer and explanation for question 2
Correct answer: D. Mesocortical pathway
The mesocortical pathway projects from the ventral tegmental area to cortical regions, including the prefrontal cortex. It is relevant to executive function and working memory. Classic review models also associate reduced mesocortical dopamine activity with negative symptoms, but a patient’s symptoms do not establish a measurable dopamine deficiency.
Why the other answers are less appropriate
- A. Tuberoinfundibular pathway: The tuberoinfundibular pathway is associated with hypothalamic regulation of prolactin.
- B. Nigrostriatal pathway: The nigrostriatal pathway connects the substantia nigra with the striatum and helps regulate movement.
- C. Mesolimbic pathway: The mesolimbic pathway includes projections to the nucleus accumbens and is associated with reward, salience, and the classic positive-symptom model.
Question 3 of 10
Two weeks after a haloperidol dose increase, a patient develops a resting tremor, slowed movements, and cogwheel rigidity. The patient is alert and afebrile, with stable vital signs. D2 blockade in which pathway best explains these findings?
Show answer and explanation for question 3
Correct answer: A. Nigrostriatal pathway
Tremor, bradykinesia, and cogwheel rigidity suggest drug-induced parkinsonism, an extrapyramidal adverse effect associated with nigrostriatal D2 blockade. The stable vital signs and absence of fever or mental-status change favor parkinsonism in this vignette. Rigidity with hyperthermia, autonomic instability, or altered mental status would require urgent evaluation for neuroleptic malignant syndrome.
Why the other answers are less appropriate
- B. Mesocortical pathway: Mesocortical projections are associated with cortical cognitive functions, rather than this motor adverse-effect pattern.
- C. Tuberoinfundibular pathway: Tuberoinfundibular blockade can increase prolactin; it does not best explain tremor and cogwheel rigidity.
- D. Mesolimbic pathway: Mesolimbic signaling is associated with reward and the classic positive-symptom model, rather than drug-induced parkinsonism.
Question 4 of 10
Six weeks after starting risperidone, a patient develops galactorrhea and missed menstrual periods. Pregnancy testing is negative and serum prolactin is elevated. Which mechanism best explains this medication effect?
Show answer and explanation for question 4
Correct answer: C. D2 blockade removes dopamine’s inhibitory effect on prolactin secretion
Dopamine normally restrains prolactin release through D2 receptors on anterior pituitary lactotrophs. Blocking this tuberoinfundibular influence can raise prolactin and produce galactorrhea or menstrual changes. Risperidone can cause this effect. The association supports a medication review; it does not eliminate the need to assess other causes when clinically indicated.
Why the other answers are less appropriate
- A. D2 activation in the tuberoinfundibular system increases prolactin release: D2 stimulation ordinarily inhibits prolactin release; this option reverses the direction of the effect.
- B. D2 blockade in the nigrostriatal pathway increases prolactin release: Nigrostriatal D2 blockade is associated with motor adverse effects, not the primary regulation of prolactin.
- D. Mesocortical dopamine release directly stimulates prolactin secretion: The mesocortical pathway is not the principal dopamine pathway regulating anterior pituitary prolactin release.
Question 5 of 10
A patient taking sertraline starts tramadol and develops agitation, sweating, diarrhea, a temperature of 38.7°C, hyperreflexia, and inducible ankle clonus within a day. Which explanation best fits this presentation?
Show answer and explanation for question 5
Correct answer: A. Excess serotonergic activity causing serotonin syndrome
The new serotonergic combination plus autonomic changes and neuromuscular hyperactivity points to serotonin syndrome. Clonus and hyperreflexia are especially useful clues. This is potentially life-threatening: stop the implicated serotonergic agents and arrange immediate emergency assessment and supportive treatment. It is not a routine adverse effect to watch at home.
Why the other answers are less appropriate
- B. Muscarinic blockade causing anticholinergic toxicity: Anticholinergic toxicity more often features dry skin or mucosa, urinary retention, and reduced bowel activity; sweating, diarrhea, and clonus favor serotonin toxicity.
- C. Nigrostriatal D2 blockade causing drug-induced parkinsonism: Drug-induced parkinsonism does not explain this abrupt combination of fever, diarrhea, autonomic activation, and clonus.
- D. Histamine H1 blockade causing excessive sedation: H1 blockade may cause somnolence but does not explain this hyperactive neuromuscular and autonomic syndrome.
Question 6 of 10
An adult starting atomoxetine for ADHD asks why the PMHNP will recheck blood pressure and pulse after dose changes. Which mechanism best connects this medication with that monitoring?
Show answer and explanation for question 6
Correct answer: B. Selective inhibition of norepinephrine reuptake
Atomoxetine selectively inhibits norepinephrine reuptake. Noradrenergic effects can increase heart rate and blood pressure, so both should be assessed at baseline, after dose increases, and periodically during treatment. Connecting the mechanism with monitoring is more useful than memorizing the drug name alone.
Why the other answers are less appropriate
- A. Potentiation of GABA-A signaling: GABA-A potentiation is a benzodiazepine mechanism, not atomoxetine’s mechanism.
- C. Blockade of muscarinic acetylcholine receptors: Muscarinic blockade does not describe atomoxetine’s primary action; a similar adverse effect does not mean two drugs share a mechanism.
- D. Antagonism of NMDA glutamate receptors: NMDA antagonism is relevant to medications such as esketamine, not atomoxetine.
Question 7 of 10
An adult receiving diazepam for medically supervised alcohol withdrawal becomes less tremulous and more sedated. Enhancement of which neurotransmitter’s action best explains the medication’s inhibitory effects?
Show answer and explanation for question 7
Correct answer: D. Gamma-aminobutyric acid (GABA)
Benzodiazepines enhance GABA-A receptor signaling. GABA is the major inhibitory neurotransmitter in the mature central nervous system, so enhancing its action helps explain anxiolytic, sedative, and anticonvulsant effects. This mechanism does not mean an anxiety disorder can be diagnosed as a simple GABA deficiency.
Why the other answers are less appropriate
- A. Glutamate: Glutamate is the major excitatory neurotransmitter. Diazepam enhances GABA-A signaling, rather than directly enhancing glutamate signaling.
- B. Acetylcholine: Acetylcholine contributes to cognition and autonomic function; muscarinic blockade is a different medication effect.
- C. Norepinephrine: Norepinephrine is associated with attention and arousal; its reuptake inhibition is a different mechanism.
Question 8 of 10
A patient being evaluated for esketamine treatment asks how its receptor target differs from that of an SSRI. Esketamine antagonizes NMDA receptors. These receptors belong to which neurotransmitter system?
Show answer and explanation for question 8
Correct answer: C. Glutamate, the major excitatory neurotransmitter
NMDA receptors are a type of glutamate receptor. Glutamate is the major excitatory neurotransmitter and contributes to learning and plasticity. Esketamine is an NMDA receptor antagonist; its prescribing information states that the mechanism producing its antidepressant effect is unknown. Receptor pharmacology should not be mistaken for a complete explanation of depression.
Why the other answers are less appropriate
- A. Serotonin, a monoamine involved in mood and anxiety: SSRIs inhibit serotonin reuptake; NMDA receptors are not serotonin receptors.
- B. GABA, the major inhibitory neurotransmitter: GABA-A signaling is enhanced by benzodiazepines, but NMDA is a glutamate receptor.
- D. Acetylcholine, involved in cognition and autonomic function: Cholinergic receptors are muscarinic or nicotinic; NMDA receptors are neither.
Question 9 of 10
An older adult develops acute confusion, dry mouth, constipation, and difficulty urinating shortly after amitriptyline is added to the medication list. Which receptor effect best explains this cluster?
Show answer and explanation for question 9
Correct answer: B. Muscarinic acetylcholine receptor blockade
This combination points to antimuscarinic, or anticholinergic, effects. Older adults are particularly vulnerable to cognitive adverse effects from amitriptyline. New confusion and urinary retention need prompt clinical assessment, including a medication review and evaluation for other causes; they should not be dismissed as expected aging.
Why the other answers are less appropriate
- A. Histamine H1 receptor blockade: H1 blockade can contribute to sedation, but it is not the best explanation for the combined dry mouth, constipation, and urinary retention.
- C. Dopamine D2 receptor activation: D2 activation does not explain this characteristic anticholinergic pattern.
- D. GABA-A receptor potentiation: GABA-A potentiation can cause sedation, but it does not best explain the peripheral anticholinergic findings.
Question 10 of 10
At follow-up after starting mirtazapine, a patient reports marked sleepiness and increased appetite. Which receptor action is most directly associated with the sedating effect?
Show answer and explanation for question 10
Correct answer: A. Histamine H1 receptor blockade
H1 blockade is a useful explanation for mirtazapine’s prominent sedation. Increased appetite and weight gain are also recognized adverse effects. H1 antagonism can contribute to appetite and weight effects, but these are multifactorial; avoid assigning all weight change to one receptor. Ask how sleepiness affects driving and daily functioning.
Why the other answers are less appropriate
- B. Peripheral alpha-1 adrenergic receptor blockade: Peripheral alpha-1 blockade is more directly associated with orthostatic hypotension.
- C. Dopamine D2 receptor blockade: D2 blockade is more useful for explaining prolactin elevation and certain movement adverse effects of antipsychotics.
- D. Muscarinic acetylcholine receptor blockade: Muscarinic blockade is more characteristic of dry mouth, constipation, urinary retention, and cognitive effects; H1 blockade is the best answer for prominent sedation here.
Turn missed questions into stronger connections
Explain the pathway or receptor behind each answer before moving on. Distinguish dopamine-related movement and prolactin effects, serotonergic toxicity, inhibitory and excitatory signaling, and anticholinergic or antihistamine effects. Use missed concepts to guide focused study; this short set does not measure clinical readiness.
Neurotransmitter review: frequently asked questions
What neurotransmitters should I know for the PMHNP exam?
Build a working understanding of dopamine, serotonin, norepinephrine, GABA, glutamate, acetylcholine, and histamine. Connect each with relevant receptors, medication effects, and adverse-effect patterns. This quiz also covers the mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular dopamine pathways.
Are dopamine pathways tested on the PMHNP boards?
Dopamine pathways are useful preparation for the neuroanatomy, neurophysiology, and psychopharmacology areas named in the ANCC test content outline. The public outline includes extrapyramidal symptoms but does not promise a specific dopamine-pathway question or its frequency. Use the current official outline to guide your overall preparation.
View the official ANCC test content outline
What is the best way to study neurotransmitters for the ANCC exam?
Study a mechanism, apply it to a clinical scenario, then explain your answer without looking at the rationale. For missed questions, write down the clue you overlooked and the reason the tempting distractor was wrong. Return to those concepts later and mix them into broader psychopharmacology review.
Review neurotransmitters for the PMHNP exam
Are these official ANCC questions?
No. These are original, independent practice questions created for PMHNP board review. They do not reproduce actual ANCC exam items, and PMHNP Playbook is not affiliated with or endorsed by ANCC. Completing this quiz does not guarantee exam success.
Keep your board review connected
Connect neurotransmitter mechanisms with assessment, medication effects, and a realistic study schedule.